Trial Profile
Prospective, observational study of eslicarbazepine acetate for the treatment of patients with epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2016
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 07 Mar 2016 New trial record